论文部分内容阅读
报告了盐酸替罗非班在84例急性ST段抬高型心肌梗死(ST elevation acute myocardial infarction,STEMI)患者急诊冠状动脉介入术(PCI)中的应用。46例患者术中、术后使用替罗非班,术后24h及30dMACE的发生率明显低于以往只用PCI的患者,并且提高了梗死相关血管(IRA)心肌灌注血流(TIMI),但使用替罗非班组的患者出血事件稍多。总之盐酸替罗非班应用于急诊PCI术治疗急性STEMI患者效果良好,可减少并发症的发生。
Reported the use of tirofiban hydrochloride in emergency PCI (Coronary Intervention) in 84 patients with ST elevation acute myocardial infarction (STEMI). Tirofiban was used intraoperatively and postoperatively in 46 patients. The incidence of MACE at 24 h and 30 d after operation was significantly lower than that of patients with previous PCI only, and increased myocardial infusing blood flow (TIMI) of infarct-related vessels (IRA) Patients treated with tirofiban had slightly more bleeding. In short, the application of tirofiban hydrochloride in emergency PCI in acute STEMI patients with good results, can reduce the incidence of complications.